vs
Side-by-side financial comparison of Dexcom (DXCM) and Symbotic Inc. (SYM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $630.0M, roughly 2.0× Symbotic Inc.). Dexcom runs the higher net margin — 21.2% vs 0.4%, a 20.8% gap on every dollar of revenue. On growth, Symbotic Inc. posted the faster year-over-year revenue change (29.4% vs 21.6%). Over the past eight quarters, Symbotic Inc.'s revenue compounded faster (21.9% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Symbotic Inc. is an American robotics warehouse automation company based in Wilmington, Massachusetts.
DXCM vs SYM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $630.0M |
| Net Profit | $267.3M | $2.6M |
| Gross Margin | 62.9% | 21.2% |
| Operating Margin | 25.6% | 1.0% |
| Net Margin | 21.2% | 0.4% |
| Revenue YoY | 21.6% | 29.4% |
| Net Profit YoY | 153.6% | 174.9% |
| EPS (diluted) | $0.67 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $630.0M | ||
| Q3 25 | $1.2B | $618.5M | ||
| Q2 25 | $1.2B | $592.1M | ||
| Q1 25 | $1.0B | $549.7M | ||
| Q4 24 | $1.1B | $486.7M | ||
| Q3 24 | $994.2M | $503.6M | ||
| Q2 24 | $1.0B | $491.9M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $2.6M | ||
| Q3 25 | $283.8M | $-3.6M | ||
| Q2 25 | $179.8M | $-5.9M | ||
| Q1 25 | $105.4M | $-3.9M | ||
| Q4 24 | $151.7M | $-3.5M | ||
| Q3 24 | $134.6M | $-2.5M | ||
| Q2 24 | $143.5M | $-2.5M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 21.2% | ||
| Q3 25 | 60.5% | 20.6% | ||
| Q2 25 | 59.5% | 18.2% | ||
| Q1 25 | 56.9% | 19.6% | ||
| Q4 24 | 58.9% | 16.4% | ||
| Q3 24 | 59.7% | 12.7% | ||
| Q2 24 | 62.4% | 13.7% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 1.0% | ||
| Q3 25 | 20.1% | -3.5% | ||
| Q2 25 | 18.4% | -6.2% | ||
| Q1 25 | 12.9% | -5.8% | ||
| Q4 24 | 17.0% | -5.1% | ||
| Q3 24 | 15.3% | -4.3% | ||
| Q2 24 | 15.7% | -5.1% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 0.4% | ||
| Q3 25 | 23.5% | -0.6% | ||
| Q2 25 | 15.5% | -1.0% | ||
| Q1 25 | 10.2% | -0.7% | ||
| Q4 24 | 13.6% | -0.7% | ||
| Q3 24 | 13.5% | -0.5% | ||
| Q2 24 | 14.3% | -0.5% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.02 | ||
| Q3 25 | $0.70 | $-0.04 | ||
| Q2 25 | $0.45 | $-0.05 | ||
| Q1 25 | $0.27 | $-0.04 | ||
| Q4 24 | $0.37 | $-0.03 | ||
| Q3 24 | $0.34 | $-0.03 | ||
| Q2 24 | $0.35 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.8B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $663.8M |
| Total Assets | $6.3B | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $1.8B | ||
| Q3 25 | $1.8B | $1.2B | ||
| Q2 25 | $1.2B | $777.6M | ||
| Q1 25 | $904.9M | $954.9M | ||
| Q4 24 | $606.1M | $903.0M | ||
| Q3 24 | $621.2M | $727.3M | ||
| Q2 24 | $939.2M | $870.5M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $663.8M | ||
| Q3 25 | $2.7B | $221.3M | ||
| Q2 25 | $2.6B | $210.8M | ||
| Q1 25 | $2.3B | $205.4M | ||
| Q4 24 | $2.1B | $196.5M | ||
| Q3 24 | $2.0B | $197.2M | ||
| Q2 24 | $2.4B | $418.7M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.0B | ||
| Q3 25 | $7.5B | $2.4B | ||
| Q2 25 | $7.3B | $1.8B | ||
| Q1 25 | $6.8B | $2.0B | ||
| Q4 24 | $6.5B | $1.7B | ||
| Q3 24 | $6.4B | $1.6B | ||
| Q2 24 | $6.8B | $1.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $191.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 73.61× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $191.5M | ||
| Q3 25 | $659.9M | $530.7M | ||
| Q2 25 | $303.0M | $-138.3M | ||
| Q1 25 | $183.8M | $269.6M | ||
| Q4 24 | $301.4M | $205.0M | ||
| Q3 24 | $199.5M | $-99.4M | ||
| Q2 24 | $279.4M | $50.4M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | $197.7M | ||
| Q3 24 | $88.3M | $-120.1M | ||
| Q2 24 | $213.3M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | 40.6% | ||
| Q3 24 | 8.9% | -23.9% | ||
| Q2 24 | 21.2% | 6.8% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | 1.5% | ||
| Q3 24 | 11.2% | 4.1% | ||
| Q2 24 | 6.6% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 73.61× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
SYM
| Systems | $590.3M | 94% |
| Operation Services | $28.8M | 5% |
| Software Maintenance And Support | $10.9M | 2% |
| Revision Of Prior Period Change In Accounting Principle Adjustment | $2.9M | 0% |
| Related Party | $1.1M | 0% |
